Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells
Cellecta’s CloneTracker XP™ was recently used in a study on oestrogen receptor-positive breast cancer relapse even after treatment with endocrine therapies (ET).
.jpg?width=50)
